1Medizinischen Klinik II für Hämatologie, Onkologie und Immunologle, St. Johannes-Hospital, Duisburg, FRG.
Intracavitary mitoxantrone showed promise in treating malignant effusions and peritoneal carcinosis. This approach led to complete or partial remission in a significant number of patients with these advanced cancers.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: